- Home
- IMXI vs CATX Comparison
IMXI vs CATX Comparison
Compare IMXI & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMXI
- CATX
- Stock Information
- Founded
- IMXI 1994
- CATX 1983
- Country
- IMXI United States
- CATX United States
- Employees
- IMXI N/A
- CATX N/A
- Industry
- IMXI Retail: Computer Software & Peripheral Equipment
- CATX Medical/Dental Instruments
- Sector
- IMXI Technology
- CATX Health Care
- Exchange
- IMXI Nasdaq
- CATX Nasdaq
- Market Cap
- IMXI 302.5M
- CATX 239.0M
- IPO Year
- IMXI N/A
- CATX N/A
- Fundamental
- Price
- IMXI $10.30
- CATX $3.97
- Analyst Decision
- IMXI Buy
- CATX Strong Buy
- Analyst Count
- IMXI 7
- CATX 11
- Target Price
- IMXI $19.60
- CATX $12.90
- AVG Volume (30 Days)
- IMXI 318.6K
- CATX 1.3M
- Earning Date
- IMXI 08-06-2025
- CATX 08-11-2025
- Dividend Yield
- IMXI N/A
- CATX N/A
- EPS Growth
- IMXI 1.60
- CATX N/A
- EPS
- IMXI 1.70
- CATX N/A
- Revenue
- IMXI $652,547,000.00
- CATX $1,471,000.00
- Revenue This Year
- IMXI N/A
- CATX N/A
- Revenue Next Year
- IMXI $3.03
- CATX N/A
- P/E Ratio
- IMXI $6.02
- CATX N/A
- Revenue Growth
- IMXI N/A
- CATX N/A
- 52 Week Low
- IMXI $9.76
- CATX $1.60
- 52 Week High
- IMXI $22.38
- CATX $16.55
- Technical
- Relative Strength Index (RSI)
- IMXI 45.01
- CATX 61.19
- Support Level
- IMXI $10.22
- CATX $3.33
- Resistance Level
- IMXI $10.87
- CATX $3.69
- Average True Range (ATR)
- IMXI 0.34
- CATX 0.38
- MACD
- IMXI 0.05
- CATX 0.01
- Stochastic Oscillator
- IMXI 48.65
- CATX 64.23
About IMXI International Money Express Inc.
International Money Express Inc is a processor of money transfer services in the USA to the Latin America and the Caribbean (LAC) corridor. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.